The Cloning and Expression of Human Monoclonal Antibodies: Implications for Allergen Immunotherapy

Louisa James*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)
205 Downloads (Pure)

Abstract

Allergic responses are dependent on the highly specific effector functions of IgE antibodies. Conversely, antibodies that block the activity of IgE can mediate tolerance to allergen. Technologies that harness the unparalleled specificity of antibody responses have revolutionized the way that we diagnose and treat human disease. This area of research continues to advance at a rapid pace and has had a significant impact on our understanding of allergic disease. This review will present an overview of humoral responses and provide an up-to-date summary of technologies used in the generation of human monoclonal antibodies. The impact that monoclonal antibodies have on allergic disease will be discussed, with a particular focus on allergen immunotherapy, which remains the only form of treatment that can modulate the underlying immune mechanisms and induce long-term clinical tolerance.

Original languageEnglish
Article number15
Pages (from-to)1-9
Number of pages9
JournalCURRENT ALLERGY AND ASTHMA REPORTS
Volume16
Issue number2
DOIs
Publication statusPublished - 1 Jan 2016

Keywords

  • Allergen immunotherapy
  • Allergy
  • B cells
  • Cloning
  • Human
  • Human monoclonal antibodies

Fingerprint

Dive into the research topics of 'The Cloning and Expression of Human Monoclonal Antibodies: Implications for Allergen Immunotherapy'. Together they form a unique fingerprint.

Cite this